Ignite Creation Date:
2025-12-24 @ 12:36 PM
Ignite Modification Date:
2026-02-21 @ 2:54 PM
Study NCT ID:
NCT04852861
Status:
COMPLETED
Last Update Posted:
2023-03-28
First Post:
2021-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine
Sponsor:
Sciensano
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-10
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-14
First Submit QC Date:
None
Study First Post Date:
2021-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-27
Last Update Post Date:
2023-03-28
Last Update Post Date Type:
ACTUAL